Primary |
Depression |
40.4% |
Drug Use For Unknown Indication |
22.4% |
Anxiety |
14.1% |
Panic Disorder |
4.6% |
Product Used For Unknown Indication |
4.3% |
Pregnancy |
2.1% |
Bipolar Disorder |
1.8% |
Panic Attack |
1.3% |
Obsessive-compulsive Disorder |
1.2% |
Anxiety Disorder |
1.1% |
Major Depression |
1.1% |
Asthma |
0.9% |
Back Pain |
0.9% |
Prophylaxis |
0.7% |
Multiple Allergies |
0.6% |
Nausea |
0.6% |
Stress |
0.6% |
Insomnia |
0.5% |
Generalised Anxiety Disorder |
0.4% |
Erectile Dysfunction |
0.4% |
|
Ventricular Septal Defect |
18.3% |
Drug Ineffective |
15.2% |
Weight Increased |
6.9% |
Drug Exposure During Pregnancy |
6.5% |
Tremor |
5.5% |
Suicidal Ideation |
5.3% |
Vomiting |
4.3% |
Nausea |
4.1% |
Somnolence |
3.9% |
Pharmaceutical Product Complaint |
3.7% |
Withdrawal Syndrome |
3.1% |
Foetal Exposure During Pregnancy |
3.0% |
Weight Decreased |
3.0% |
Paraesthesia |
2.8% |
Tricuspid Valve Incompetence |
2.8% |
Insomnia |
2.7% |
Patent Ductus Arteriosus |
2.3% |
Suicide Attempt |
2.3% |
Therapeutic Response Decreased |
2.2% |
Pulmonary Artery Stenosis Congenital |
2.1% |
|
Secondary |
Depression |
37.5% |
Anxiety |
16.5% |
Product Used For Unknown Indication |
14.9% |
Drug Use For Unknown Indication |
12.1% |
Bipolar Disorder |
2.8% |
Panic Disorder |
2.4% |
Obsessive-compulsive Disorder |
1.9% |
Asthma |
1.8% |
Panic Attack |
1.8% |
Stress |
1.2% |
Dyspnoea |
1.0% |
Pregnancy |
0.9% |
Pain |
0.9% |
Post-traumatic Stress Disorder |
0.8% |
Postpartum Depression |
0.7% |
Anxiety Disorder |
0.6% |
Migraine |
0.6% |
Constipation |
0.6% |
Hormone Replacement Therapy |
0.5% |
Psychomotor Retardation |
0.5% |
|
Ventricular Septal Defect |
25.9% |
Multiple Congenital Abnormalities |
8.6% |
Drug Exposure During Pregnancy |
7.8% |
Vomiting |
6.8% |
Weight Increased |
6.3% |
Suicidal Ideation |
6.1% |
Patent Ductus Arteriosus |
5.3% |
Drug Ineffective |
4.8% |
Heart Disease Congenital |
4.0% |
Suicide Attempt |
3.8% |
Premature Baby |
2.7% |
Talipes |
2.7% |
Tremor |
2.3% |
Weight Decreased |
2.3% |
Pulmonary Artery Stenosis Congenital |
2.1% |
Pulmonary Valve Stenosis |
2.1% |
Sleep Apnoea Syndrome |
1.9% |
Withdrawal Syndrome |
1.7% |
Respiratory Distress |
1.5% |
Somnolence |
1.5% |
|
Concomitant |
Drug Use For Unknown Indication |
18.3% |
Depression |
15.8% |
Product Used For Unknown Indication |
11.5% |
Anxiety |
8.1% |
Bipolar Disorder |
5.5% |
Sleep Disorder |
4.2% |
Insomnia |
3.8% |
Medical Diet |
3.7% |
Pain |
3.6% |
Hypertension |
3.5% |
Gastrooesophageal Reflux Disease |
3.1% |
Non-small Cell Lung Cancer |
3.0% |
Prophylaxis |
2.7% |
Rheumatoid Arthritis |
2.4% |
Smoking Cessation Therapy |
2.3% |
Diabetes Mellitus |
2.0% |
Diarrhoea |
1.9% |
Panic Attack |
1.6% |
Anaemia |
1.5% |
Asthma |
1.4% |
|
Type 2 Diabetes Mellitus |
19.3% |
Weight Increased |
13.9% |
Vision Blurred |
7.1% |
Drug Ineffective |
6.8% |
Thrombocytopenia |
5.1% |
Suicidal Ideation |
4.7% |
Pulmonary Embolism |
4.1% |
Weight Decreased |
4.1% |
Cerebrovascular Accident |
3.7% |
Pancreatitis |
3.7% |
Tremor |
3.7% |
Somnolence |
3.4% |
Suicide Attempt |
3.1% |
Urinary Tract Infection |
3.1% |
Vomiting |
2.7% |
Withdrawal Syndrome |
2.7% |
Myocardial Infarction |
2.4% |
Pain In Extremity |
2.4% |
Diabetic Retinopathy |
2.0% |
Insomnia |
2.0% |
|
Interacting |
Blood Cholesterol Increased |
25.0% |
Hypertension |
25.0% |
Ill-defined Disorder |
25.0% |
Smoking Cessation Therapy |
25.0% |
|
|